Shanghai Korey Pharm Co.,Ltd, founded in Shanghai in 2010, is entirely funded by and affiliated to Chongqing Kerui Pharmaceutical Corp., Ltd which was established more than a century ago. With the support of its holding company's complete range of industrial chains in health care domain, Kerui delivers to global clients four categories of products: pharmaceutical chemical material intermediates, plant extracts, medicinal slices of traditional Chinese medicine, and pharmaceutical health care products. In addition, such services as OEM/ ODM and importation distributions are available in our corporation.

Our advantages:

1. Our manufacture system covers a complete range of industrial chains for chemical drugs and traditional Chinese medicine (TCM): chemical drugs are classified into pharmaceutical intermediates, active pharmaceutical ingredients (API) and chemical preparations; and traditional Chinese medicine includes good agriculture practice (GAP), processing of TCM medicinal slices, TCM extraction, TCM preparations and health care products.

2. Good manufacturing practice (GMP) for all products: as a pharmaceutical industry, our holding corporation's production lines for chemical drugs, traditional Chinese medicine, active pharmaceutical ingredients (API) and pharmaceutical intermediates have passed national GMP authentication.

3. Multi-manufacture bases: manufacture bases are established in accordance with each specific type of product, among which there are two bases for pharmaceutical chemical material intermediates, two for plant extracts, and three for the production of pharmaceutical health care products, with each base poccessing separate quality assurance and inspection systems.

4. Well-appointed facilities for production: manufacture bases for pharmaceutial chemical products are qualified for the production of pharmaceutical intermediates and active pharmaceutical ingredients; Manufacture bases for plant extracts are capable of processing ratio extracts, index components and monomer components; Manufacture bases for pharmaceutical health care products are in a position to produce oral-intake controlled release preparations, routine oral preparations (such as capsules, granules, troche and oral liquid) as well as powder-needle preparations.

5. Tremendous strength in research and development (R&D): equipments with a total value of approximately 20 million RMB are available in our pharmaceutical technical center at a provincial level which incorporates institutions for formula, technology, quality advancement, lab research and pilot plant.

6.Enormous sales pipelines for pharmaceutical products: 7 commercial companies distributed in middle and western China are affiliated to our corporation, playing a significant role in terminal sales. It is sincerely expected that taking full advantage of its resources, our corporation can seek more cooperation in an all-round manner with clients from home and abroad, and deliver more benefits to them through satisfactory services.